Ancora Advisors’s CONMED CNMD Stock Holding History

Ancora Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-76	Closed	-$3.09K	–	2428
2025 Q4	$3.09K	Buy	+76	New	+$3.31K	﹤0.01%	2063

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Ancora Advisors's CNMD Position: Q1 2026 in Review

Ancora Advisors sold out of CONMED (CNMD) in Q1 2026, closing a stake of 76 shares — an estimated $3.09K sold.

Ancora Advisors first reported a position in CNMD in Q4 2025 and held it in 1 quarter. The position peaked at $3.09K in Q4 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

Ancora Advisors reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
Ancora Advisors sold 76 CONMED shares in Q1 2026, an estimated $3.09K.
Ancora Advisors first reported a position in CONMED in Q4 2025 and held it in 1 quarter.
Ancora Advisors's CONMED position peaked at $3.09K in Q4 2025.
236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.